Metreleptin

CHEMBL2107857 Phase 4 معتمد Protein
Half-Life
Bioavailability
Protein Binding
Molecular Weight
g/mol
LogP
Phase
4

This injectable protein mimics the hormone leptin, which helps regulate appetite, metabolism, and insulin sensitivity. It is used to treat complications of leptin deficiency in patients with certain rare fat-tissue disorders.

المجالات العلاجية

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

الأسئلة الشائعة

This injectable protein mimics the hormone leptin, which helps regulate appetite, metabolism, and insulin sensitivity. It is used to treat complications of leptin deficiency in patients with certain rare fat-tissue disorders.

Yes, Metreleptin is an approved drug. It has reached clinical phase 4. It is classified as a Protein.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2107857. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

إخلاء المسؤولية الطبية

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.